Psychiatry and Neurology, Neurology · Kansas City, KS
NPI
1255438164
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
6
Hospital affiliations
3901 Rainbow Blvd, 4070 Delp Mail Stop 4017
Kansas City, KS, 66160
Phone (913) 588-6970
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
1,640 services
Medicare patients, 2024
557
Average age 75
Drug cost, 2024
$4.7M
10,065 prescriptions
Company payments, 2025
$126K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajesh Pahwa was code 99214 (office e&m - established), 963 times for 519 patients. In total Rajesh Pahwa billed 1,640 services in 16 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 963 | 519 | $63.92 | $62K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 450 | 340 | $11.22 | $5,047 |
| 64611 Musculoskeletal | Office | 58 | 24 | $64.12 | $3,719 |
| 99213 Office E&M - Established | Office | 47 | 38 | $40.56 | $1,906 |
| 99483 Office/Outpatient Services | Office | 37 | 37 | $121.75 | $4,505 |
| 99204 Office E&M - New | Office | 20 | 20 | $81.98 | $1,640 |
| 95983 Electrical Nerve Conductivity | Office | 15 | 14 | $30.13 | $452 |
By year: 2022 $87K for 1,280 services; 2023 $78K for 1,239 services; 2024 $82K for 1,640 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rajesh Pahwa prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,990 prescriptions and refills. In total Rajesh Pahwa wrote 10,065 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,990 | 4,825 | 489 | $101K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 775 | 1,795 | 202 | $52K |
| Amantadine Amantadine Hcl | 535 | 1,225 | 130 | $29K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 393 | 1,086 | 113 | $10K |
| Nuplazid Pimavanserin Tartrate | 336 | 442 | 53 | $2.1M |
| Rytary Carbidopa/Levodopa | 319 | 572 | 58 | $466K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 295 | 648 | 54 | $8,914 |
| Escitalopram Oxalate Generic | 293 | 631 | 72 | $3,823 |
| Rivastigmine Rivastigmine Tartrate | 263 | 527 | 71 | $19K |
| Gabapentin Generic | 255 | 571 | 63 | $4,000 |
| Mirtazapine Generic | 241 | 517 | 65 | $2,809 |
| Quetiapine Fumarate Generic | 227 | 373 | 43 | $3,334 |
| Rasagiline Mesylate Generic | 214 | 529 | 63 | $32K |
| Clonazepam Generic | 205 | 287 | 36 | $2,359 |
| Trazodone Hcl Generic | 200 | 475 | 56 | $1,180 |
Brand drugs: 1,418 claims; generic drugs: 8,647 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajesh Pahwa $126K ($126K in general payments such as food, travel and fees) from 15 companies. The largest payer was MDD US Operations, LLC with $78K.
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 92 | $78K |
| Abbvie Inc. ABBV | 15 | $16K |
| H. Lundbeck A S HLUN-A.CO | 6 | $10K |
| Genentech USA, Inc. ROG.SW | 7 | $7,903 |
| ACADIA Pharmaceuticals Inc ACAD | 7 | $6,435 |
| ConvaTec Inc. CTEC.L | 3 | $5,250 |
| Abbott Laboratories ABT | 7 | $1,464 |
| Tanabe Pharma America, Inc. | 1 | $625 |
| Sage Therapeutics, LLC SAGE | 1 | $531 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $34.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.